Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells

Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans due to late detection and highly metastatic characteristics. PDAC cells vary in their tumorigenic capabilities with the presence of a subset of PDAC cells known as pancreatic cancer stem cells (CSCs), which are more...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Stoica, A, Chang, C-H, Pauklin, S
Natura:	Journal article
Lingua:	English
Pubblicazione:	Cell Press 2020

Documenti analoghi

Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
di: Pook, H, et al.
Pubblicazione: (2021)

In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader
di: Parvin Yavari, et al.
Pubblicazione: (2024-10-01)

TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
di: Ahmad Taha Khalaf, et al.
Pubblicazione: (2023-03-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
di: Gitika Thakur, et al.
Pubblicazione: (2021-02-01)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
di: Jinlu Liu, et al.
Pubblicazione: (2023-10-01)

Identifying the mechanisms driving pancreatic ductal adenocarcinoma stem cell characteristics using single-cell RNA-sequencing
di: Stoica, AF
Pubblicazione: (2023)

BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma
di: Feng, Y, et al.
Pubblicazione: (2023)

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
di: Silvana Debernardi, et al.
Pubblicazione: (2024-03-01)

Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
di: Mehran Taherian, et al.
Pubblicazione: (2022-09-01)

Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma
di: Jiatong Wang, et al.
Pubblicazione: (2023-08-01)

The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
di: Yuanyuan Wei, et al.
Pubblicazione: (2023-04-01)

Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma
di: Shiye Ruan, et al.
Pubblicazione: (2024-03-01)

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
di: Andrea Vallés‐Martí, et al.
Pubblicazione: (2024-08-01)

Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
di: Ruining Gong, et al.
Pubblicazione: (2023-12-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
di: Apeksha Kakkar, et al.
Pubblicazione: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
di: Nausika Betriu, et al.
Pubblicazione: (2021-02-01)

Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
di: Maria Dobre, et al.
Pubblicazione: (2021-07-01)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
di: Wang, L, et al.
Pubblicazione: (2015)

Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma
di: Abhirup Chatterjee, et al.
Pubblicazione: (2023-12-01)

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
di: Sona Ciernikova, et al.
Pubblicazione: (2020-12-01)

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
di: Heng‐Chung Kung, et al.
Pubblicazione: (2023-04-01)

Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
di: James M. Halle-Smith, et al.
Pubblicazione: (2023-12-01)

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
di: Wanting Hou, et al.
Pubblicazione: (2022-09-01)

The T cell architecture of pancreatic ductal adenocarcinoma
di: Sivakumar, S, et al.
Pubblicazione: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
di: Sivakumar, S, et al.
Pubblicazione: (2019)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
di: Shengnan Lv, et al.
Pubblicazione: (2023-12-01)

Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma
di: Naga Malleswara Rao Nakka, et al.
Pubblicazione: (2024-10-01)

Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma
di: Simin Wang, et al.
Pubblicazione: (2024-04-01)

Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
di: Gonçalo Mesquita, et al.
Pubblicazione: (2021-04-01)

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
di: Ole Helm, et al.
Pubblicazione: (2014-01-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
di: Katarzyna Winter, et al.
Pubblicazione: (2019-03-01)

Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments
di: Doaa Bugazia, et al.
Pubblicazione: (2024-07-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
di: Peiyi Liu, et al.
Pubblicazione: (2024-11-01)

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
di: John G. Yuen, et al.
Pubblicazione: (2024-03-01)

Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
di: Eun-Jeong Won, et al.
Pubblicazione: (2022-01-01)

The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities
di: Inês Mendes, et al.
Pubblicazione: (2024-12-01)

A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma
di: Jessica Hung, et al.
Pubblicazione: (2023-03-01)

SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma.
di: Clara Simon, et al.
Pubblicazione: (2024-08-01)

Imaging p53 in pancreatic ductal adenocarcinoma
di: Koustoulidou, S
Pubblicazione: (2017)

PKM2 is not required for pancreatic ductal adenocarcinoma
di: Danai, Laura V, et al.
Pubblicazione: (2018)